tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

Noxopharm’s SOF-SKN™ Passes Key Safety Tests Ahead of Clinical Trials
Company AnnouncementsNoxopharm’s SOF-SKN™ Passes Key Safety Tests Ahead of Clinical Trials
20d ago
NOX
Noxopharm Ltd. Issues Convertible Notes to Enhance Capital Structure
PremiumCompany Announcements
Noxopharm Ltd. Issues Convertible Notes to Enhance Capital Structure
1M ago
NOX
Noxopharm Issues New Unquoted Equity Securities
PremiumCompany Announcements
Noxopharm Issues New Unquoted Equity Securities
1M ago
NOX
Noxopharm Ltd. Announces Issuance of New Unquoted Equity Securities
PremiumCompany Announcements
Noxopharm Ltd. Announces Issuance of New Unquoted Equity Securities
1M ago
NOX
Noxopharm Faces Convertible Note Issuance Delay
PremiumCompany Announcements
Noxopharm Faces Convertible Note Issuance Delay
2M ago
NOX
Noxopharm Partners with CRO for HERACLES Trial
PremiumCompany AnnouncementsNoxopharm Partners with CRO for HERACLES Trial
3M ago
NOX
Noxopharm Achieves Key Approvals at Annual Meeting
Premium
Company Announcements
Noxopharm Achieves Key Approvals at Annual Meeting
3M ago
NOX
Noxopharm Unveils Strategic Advances and Market Prospects
Premium
Company Announcements
Noxopharm Unveils Strategic Advances and Market Prospects
3M ago
NOX
Noxopharm Advances in Biotech with Promising Developments
PremiumCompany Announcements
Noxopharm Advances in Biotech with Promising Developments
3M ago
NOX
Noxopharm Strengthens Cash Reserves with R&D Rebate
PremiumCompany Announcements
Noxopharm Strengthens Cash Reserves with R&D Rebate
3M ago
NOX
Noxopharm Ltd. Announces New Securities Issuance
PremiumCompany Announcements
Noxopharm Ltd. Announces New Securities Issuance
4M ago
NOX
Noxopharm Secures New Funding with Convertible Note
PremiumCompany Announcements
Noxopharm Secures New Funding with Convertible Note
4M ago
NOX
Noxopharm Gains Investor Interest and Expands Drug Trials
PremiumCompany AnnouncementsNoxopharm Gains Investor Interest and Expands Drug Trials
4M ago
NOX
Noxopharm Announces Key 2024 AGM Details
Premium
Company Announcements
Noxopharm Announces Key 2024 AGM Details
4M ago
NOX
Noxopharm Alerts on Option Expiries, Highlights Innovation
Premium
Company Announcements
Noxopharm Alerts on Option Expiries, Highlights Innovation
5M ago
NOX
Noxopharm Advances Autoimmune Drug to Clinical Trials
PremiumCompany Announcements
Noxopharm Advances Autoimmune Drug to Clinical Trials
5M ago
NOX
Noxopharm Reports Growth and Innovation in 2024
PremiumCompany Announcements
Noxopharm Reports Growth and Innovation in 2024
5M ago
NOX
Noxopharm Reports Progress and Reduced Annual Loss
PremiumCompany Announcements
Noxopharm Reports Progress and Reduced Annual Loss
5M ago
NOX
Noxopharm Releases Key Governance Documents
PremiumCompany Announcements
Noxopharm Releases Key Governance Documents
5M ago
NOX
Noxopharm Announces New Securities Issue
PremiumCompany AnnouncementsNoxopharm Announces New Securities Issue
5M ago
NOX
Noxopharm Secures A$2.1M Convertible Notes Investment
Premium
Company Announcements
Noxopharm Secures A$2.1M Convertible Notes Investment
5M ago
NOX
Noxopharm Finalizes SOF-SKN Formula, Gains Global Interest
Premium
Company Announcements
Noxopharm Finalizes SOF-SKN Formula, Gains Global Interest
5M ago
NOX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >